Integra LifeSciences Holdings Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Mojdeh Poul
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 3.8yrs |
| Board average tenure | 11.8yrs |
Recent management updates
Recent updates
CEO
Mojdeh Poul (60 yo)
less than a year
Tenure
Ms. Mojdeh Poul is President, CEO & Director of Integra LifeSciences Holdings Corporation from January 6, 2025. Ms. Poul serves as Independent Director at iRhythm Technologies, Inc. since June 1, 2023. She...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Non- Executive Chairman | 27.2yrs | US$422.52k | 2.27% € 43.9m | |
| Executive VP & CFO | 1.7yrs | US$1.67m | 0.054% € 1.0m | |
| Senior VP of Finance & Principal Accounting Officer | 7.3yrs | US$1.25m | 0.047% € 903.5k | |
| Executive VP | 6.3yrs | US$1.62m | 0.077% € 1.5m | |
| Executive VP & President of Tissue Technologies | 12.2yrs | US$1.42m | 0.084% € 1.6m | |
| Executive VP & President of Codman Specialty Surgical | 4.8yrs | US$2.83m | 0.073% € 1.4m | |
| President | less than a year | no data | no data | |
| Corporate VP of Global Operations & Supply Chain | 4.5yrs | no data | no data | |
| Vice President of Global Corporate Communications & Public Relations | no data | no data | no data | |
| Vice President of Global Marketing | no data | no data | no data | |
| Executive VP & Chief Human Resources Officer | 2.1yrs | no data | 0.032% € 610.2k | |
| Corporate VP & Chief Digital Officer | 3.1yrs | no data | no data |
3.8yrs
Average Tenure
58yo
Average Age
Experienced Management: IL3's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Non- Executive Chairman | 27.2yrs | US$422.52k | 2.27% € 43.9m | |
| President | less than a year | no data | no data | |
| Independent Director | 15.8yrs | US$297.54k | 0.11% € 2.1m | |
| Independent Director | 19.1yrs | US$293.28k | 0.082% € 1.6m | |
| Independent Presiding Director | 11.8yrs | US$342.54k | 0.18% € 3.4m | |
| Independent Director | 33.1yrs | US$306.31k | 0.091% € 1.8m | |
| Independent Director | 1.2yrs | US$90.68k | 0.016% € 312.7k | |
| Independent Director | 3.8yrs | US$260.04k | 0.028% € 548.8k | |
| Independent Director | 2.6yrs | US$297.54k | 0.021% € 404.3k |
11.8yrs
Average Tenure
63yo
Average Age
Experienced Board: IL3's board of directors are seasoned and experienced ( 11.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/05 06:24 |
| End of Day Share Price | 2025/02/05 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Integra LifeSciences Holdings Corporation is covered by 30 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Matthew Taylor | Barclays |
| Charley Jones | Barrington Research Associates, Inc. |